Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases

被引:139
作者
Fujita, N
Nagahashi, A
Nagashima, K
Rokudai, S
Tsuruo, T
机构
[1] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan
[2] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Toshima Ku, Tokyo 1708455, Japan
关键词
Bcl-X-L; apoptosis; IL-2; caspase-3;
D O I
10.1038/sj.onc.1202065
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-2 (IL-2)-dependent T cell clone CTLL-2 underwent apoptosis by deprivation of IL-2 from culture medium. The decrease in the anti-apoptotic Bcl-X-L protein level was observed during apoptosis after IL-2 withdrawal, We found that Bcl-X-L protein was cleaved to produce two 18 kDa fragments during CTLL-2 cell apoptosis. When the activation of caspases was suppressed by overexpressing human Bcl-2 protein or by the addition of caspase inhibitors, cleavage of Bcl-X-L protein was suppressed in vivo. Bcl-X-L protein cleavage by incubation with apoptosed CTLL-2 cell lysate was suppressed by the caspase-3/CPP32-specific tetrapeptide inhibitor in vitro. Therefore, caspase-3/CPP32-like proteases were activated and involved in the cleavage of Bcl-X-L protein during CTLL-2 cell apoptosis. We found that Bcl-X-L protein was cleaved by caspase-3/CPP32 at two sites in the loop domain (i.e., HLAD(61 down arrow)S and SSLD(76 down arrow)A), The transfection of the carboxy-terminal 18 kDa Bcl-X-L fragment increased the sensitivity to apoptosis. These results indicate that caspase-3/CPP32-like proteases cleaved anti-apoptotic Bcl-X-L protein and resulted in accelerated apoptotic cell death.
引用
收藏
页码:1295 / 1304
页数:10
相关论文
共 54 条
[1]   Human ICE/CED-3 protease nomenclature [J].
Alnemri, ES ;
Livingston, DJ ;
Nicholson, DW ;
Salvesen, G ;
Thornberry, NA ;
Wong, WW ;
Yuan, JY .
CELL, 1996, 87 (02) :171-171
[2]   Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors [J].
Armstrong, RC ;
Aja, T ;
Xiang, JL ;
Gaur, S ;
Krebs, JF ;
Hoang, K ;
Bai, X ;
Korsmeyer, J ;
Karanewsky, DS ;
Fritz, LC ;
Tomaselli, KJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16850-16855
[3]  
Boise L H, 1995, Curr Top Microbiol Immunol, V200, P107
[4]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[5]  
Boulakia CA, 1996, ONCOGENE, V12, P529
[6]  
BROOME HE, 1995, J IMMUNOL, V155, P2311
[7]   Identification of a novel regulatory domain in Bcl-x(L) and Bcl-2 [J].
Chang, BS ;
Minn, AJ ;
Muchmore, SW ;
Fesik, SW ;
Thompson, CB .
EMBO JOURNAL, 1997, 16 (05) :968-977
[8]   Conversion of Bcl-2 to a Bax-like death effector by caspases [J].
Cheng, EHY ;
Kirsch, DG ;
Clem, RJ ;
Ravi, R ;
Kastan, MB ;
Bedi, A ;
Ueno, K ;
Hardwick, JM .
SCIENCE, 1997, 278 (5345) :1966-1968
[9]  
Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4573
[10]   Modulation of cell death by Bcl-xL through caspase interaction [J].
Clem, RJ ;
Cheng, EHY ;
Karp, CL ;
Kirsch, DG ;
Ueno, K ;
Takahashi, A ;
Kastan, MB ;
Griffin, DE ;
Earnshaw, WC ;
Veliuona, MA ;
Hardwick, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :554-559